Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Q1 2022 vs. Q4 2021
How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 148 | 149 | +1 |
| Shares | 63.2M | 64.4M | +1.15M (+1.8%) |
| Value | $1.38B | $1.02B | −$360.4M (−26.1%) |
New holders (22)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (21)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Great Point Partners LLC | 500,526 | $10.9M |
| Natixis | 225,394 | $4.92M |
| Marshall Wace, LLP | 95,569 | $2.08M |
| SG Americas Securities, LLC | 79,622 | $1.74M |
| Duality Advisers, LP | 48,943 | $1.07M |
| Schonfeld Strategic Advisors LLC | 41,400 | $903.0K |
| Toronto Dominion Bank | 40,588 | $886.0K |
| HRT Financial LP | 36,251 | $791.0K |
| Ergoteles LLC | 35,843 | $782.0K |
| Gsa Capital Partners LLP | 35,704 | $779.0K |
| Janus Henderson Group PLC | 15,957 | $348.0K |
| Weiss Multi-Strategy Advisers LLC | 15,075 | $329.0K |
| Jane Street Group, LLC | 10,925 | $239.0K |
| Corton Capital Inc. | 10,873 | $237.0K |
| Handelsbanken Fonder AB | 9,600 | $210.0K |
| Allstate Corp | 9,288 | $203.0K |
| Amundi | 3,836 | $71.0K |
| Dark Forest Capital Management LP | 326 | $7.00K |
| Aquatic Capital Management LLC | 200 | $4.00K |
| Captrust Financial Advisors | 39 | $1.00K |
| Tarbox Family Office, Inc. | 49 | $1.00K |